193 related articles for article (PubMed ID: 27990661)
1. Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.
Klaassen Z; Howard LE; Moreira DM; Andriole GL; Terris MK; Freedland SJ
Prostate; 2017 Apr; 77(5):466-470. PubMed ID: 27990661
[TBL] [Abstract][Full Text] [Related]
2. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
3. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer.
Bañez LL; Hamilton RJ; Partin AW; Vollmer RT; Sun L; Rodriguez C; Wang Y; Terris MK; Aronson WJ; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
JAMA; 2007 Nov; 298(19):2275-80. PubMed ID: 18029831
[TBL] [Abstract][Full Text] [Related]
4. Dihydrotestosterone and testosterone levels in men screened for prostate cancer: a study of a randomized population.
Gustafsson O; Norming U; Gustafsson S; Eneroth P; Aström G; Nyman CR
Br J Urol; 1996 Mar; 77(3):433-40. PubMed ID: 8814852
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
Kjaer TN; Ornstrup MJ; Poulsen MM; Jørgensen JO; Hougaard DM; Cohen AS; Neghabat S; Richelsen B; Pedersen SB
Prostate; 2015 Sep; 75(12):1255-63. PubMed ID: 25939591
[TBL] [Abstract][Full Text] [Related]
6. Serum testosterone and dihydrotestosterone and prostate cancer risk in the placebo arm of the Reduction by Dutasteride of Prostate Cancer Events trial.
Muller RL; Gerber L; Moreira DM; Andriole G; Castro-Santamaria R; Freedland SJ
Eur Urol; 2012 Nov; 62(5):757-64. PubMed ID: 22658758
[TBL] [Abstract][Full Text] [Related]
7. [Association between obesity-related plasma hemodilution and the concentration of prostate specific antigen].
Li F; Yin X; Li D; Yin Z; Qi S; Shi H; Gao J; Zhang X
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1721-4. PubMed ID: 26714904
[TBL] [Abstract][Full Text] [Related]
8. Serum prostate-specific antigen concentration and hemodilution among Chinese middle-aged obese men: a hematocrit-based equation for plasma volume estimation is induced.
Li F; Shen Z; Lu Y; Yun J; Fan Y
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1731-4. PubMed ID: 22850805
[TBL] [Abstract][Full Text] [Related]
9. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
[TBL] [Abstract][Full Text] [Related]
10. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
11. Relationship between prostate-specific antigen and hematocrit: does hemodilution lead to lower PSA concentrations in men with a higher body mass index?
Ohwaki K; Endo F; Muraishi O; Hiramatsu S; Yano E
Urology; 2010 Mar; 75(3):648-52. PubMed ID: 19854477
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution.
Kryvenko ON; Diaz M; Matoso A; Kates M; Cohen J; Swanson GP; Epstein JI
Urology; 2016 Apr; 90():141-7. PubMed ID: 26773349
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trial.
Idan A; Griffiths KA; Harwood DT; Seibel MJ; Turner L; Conway AJ; Handelsman DJ
Ann Intern Med; 2010 Nov; 153(10):621-32. PubMed ID: 21079217
[TBL] [Abstract][Full Text] [Related]
14. Serum androgens and prostate-specific antigen levels in androgenetic alopecia: is there a difference between frontal and vertex baldness?
Lis-Święty A; Arasiewicz H; Ranosz-Janicka I; Brzezińska-Wcisło L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1815-1818. PubMed ID: 29237093
[TBL] [Abstract][Full Text] [Related]
15. The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.
Wallner LP; Morgenstern H; McGree ME; Jacobson DJ; St Sauver JL; Jacobsen SJ; Sarma AV
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):501-8. PubMed ID: 21242331
[TBL] [Abstract][Full Text] [Related]
16. Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.
Zhang J; Ma M; Nan X; Sheng B
Braz J Med Biol Res; 2016 Jul; 49(8):. PubMed ID: 27409334
[TBL] [Abstract][Full Text] [Related]
17. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
18. Relationship between prostate-specific antigen and obesity in prostate cancer screening: analysis of a large cohort in Japan.
Kubota Y; Seike K; Maeda S; Shinohara Y; Iwata M; Sugimoto N
Int J Urol; 2011 Jan; 18(1):72-5. PubMed ID: 21198939
[TBL] [Abstract][Full Text] [Related]
19. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
